Katoh H, Ishikawa S. Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations. J Hum Genet. 2021;66(9):887–99.

Article  PubMed  PubMed Central  Google Scholar 

Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, et al. The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun. 2021;41(8):747–95.

Article  Google Scholar 

Kalan Farmanfarma K, Mahdavifar N, Hassanipour S, Salehiniya H. Epidemiologic study of gastric cancer in Iran: a systematic review. Clin Exp Gastroenterol. 2020;13:511–42.

Article  PubMed  PubMed Central  Google Scholar 

Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. Cancer J Clin. 2021;71(3):264–79.

Article  Google Scholar 

Zhang X-y, Zhang P-y. Gastric cancer: somatic genetics as a guide to therapy. J Med Genet. 2017;54(5):305–12.

Article  CAS  PubMed  Google Scholar 

Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21(11):4012.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brenkman HJ, Haverkamp L, Ruurda JP, van Hillegersberg R. Worldwide practice in gastric cancer surgery. World J Gastroenterol. 2016;22(15):4041.

Article  PubMed  PubMed Central  Google Scholar 

Burdette DL, Vance RE. STING and the innate immune response to nucleic acids in the cytosol. Nat Immunol. 2013;14(1):19–26.

Article  CAS  PubMed  Google Scholar 

Zheng J, Mo J, Zhu T, Zhuo W, Yi Y, Hu S, et al. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy. Mol Cancer. 2020;19(1):1–19.

Article  Google Scholar 

Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS–STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021;21(9):548–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang C, Shang G, Gui X, Zhang X, Bai X-c, Chen ZJ. Structural basis of STING binding with and phosphorylation by TBK1. Nature. 2019;567(7748):394–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science. 2015;347(6227):aaa2630.

Article  PubMed  Google Scholar 

Gammelgaard KR, Sandfeld-Paulsen B, Godsk SH, Demuth C, Meldgaard P, Sorensen BS, et al. cGAS-STING pathway expression as a prognostic tool in NSCLC. Translational Lung Cancer Research. 2021;10(1):340.

Article  CAS  Google Scholar 

Yang C-A, Huang H-Y, Chang Y-S, Lin C-L, Lai I-L, Chang J-G. DNA-sensing and nuclease gene expressions as markers for colorectal cancer progression. Oncology. 2017;92(2):115–24.

Article  CAS  PubMed  Google Scholar 

Song S, Peng P, Tang Z, Zhao J, Wu W, Li H, et al. Decreased expression of STING predicts poor prognosis in patients with gastric cancer. Sci Rep. 2017;7(1):1–13.

Google Scholar 

Bu Y, Liu F, Jia Q-A, Yu S-N. Decreased expression of TMEM173 predicts poor prognosis in patients with hepatocellular carcinoma. PLoS ONE. 2016;11(11): e0165681.

Article  PubMed  PubMed Central  Google Scholar 

Xia T, Konno H, Barber GN. Recurrent loss of STING signaling in melanoma correlates with susceptibility to viral OncolysisSTING deregulation in human melanoma. Can Res. 2016;76(22):6747–59.

Article  CAS  Google Scholar 

Fang C, Weng T, Hu S, Yuan Z, Xiong H, Huang B, et al. IFN-γ-induced ER stress impairs autophagy and triggers apoptosis in lung cancer cells. Oncoimmunology. 2021;10(1):1962591.

Article  PubMed  PubMed Central  Google Scholar 

Ni L, Lu J. Interferon gamma in cancer immunotherapy. Cancer Med. 2018;7(9):4509–16.

Article  PubMed  PubMed Central  Google Scholar 

Kochupurakkal BS, Wang ZC, Hua T, Culhane AC, Rodig SJ, Rajkovic-Molek K, et al. RelA-induced interferon response negatively regulates proliferation. PLoS ONE. 2015;10(10): e0140243.

Article  PubMed  PubMed Central  Google Scholar 

Wang L, Wang Y, Song Z, Chu J, Qu X. Deficiency of interferon-gamma or its receptor promotes colorectal cancer development. J Interferon Cytokine Res. 2015;35(4):273–80.

Article  CAS  PubMed  Google Scholar 

Li W, Huang X, Tong H, Wang Y, Zhang T, Wang W, et al. Comparison of the regulation of β-catenin signaling by type I, type II and type III interferons in hepatocellular carcinoma cells. PLos ONE. 2012. https://doi.org/10.1371/journal.pone.0047040.

Article  PubMed  PubMed Central  Google Scholar 

Sharma P, Pachynski RK, Narayan V, Fléchon A, Gravis G, Galsky MD, et al. Nivolumab plus ipilimumab for metastatic castration-resistant prostate cancer: preliminary analysis of patients in the CheckMate 650 trial. Cancer Cell. 2020;38(4):489-99.e3.

Article  CAS  PubMed  Google Scholar 

Ayers M, Lunceford J, Nebozhyn M, Murphy E, Loboda A, Kaufman DR, et al. IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade. J Clin Investig. 2017;127(8):2930–40.

Article  PubMed  PubMed Central  Google Scholar 

Ghaffari A, Peterson N, Khalaj K, Vitkin N, Robinson A, Francis J-A, et al. STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer. Br J Cancer. 2018;119(4):440–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim YJ. STINGing the tumor’s immune evasion mechanism. OncoImmunology. 2018;7(4): e1083673.

Article  PubMed  PubMed Central  Google Scholar 

Xia T, Konno H, Ahn J, Barber GN. Deregulation of STING signaling in colorectal carcinoma constrains DNA damage responses and correlates with tumorigenesis. Cell Rep. 2016;14(2):282–97.

Article  CAS  PubMed  Google Scholar 

Lee JH, Chang KK, Yoon C, Tang LH, Strong VE, Yoon SS. Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma. Ann Surg. 2018;267(1):105–13.

Article  PubMed  Google Scholar 

Imani M, Mohajeri N, Rastegar M, Zarghami N. Synthesis and characterization of N-rich fluorescent bio-dots as a reporter in the design of dual-labeled FRET probe for TaqMan PCR: a feasibility study. Biotechnol Appl Biochem. 2023;70(2):645–58.

Article  CAS  PubMed  Google Scholar 

Nakajima C, Uekusa Y, Iwasaki M, Yamaguchi N, Mukai T, Gao P, et al. A role of interferon-γ (IFN-γ) in tumor immunity: T cells with the capacity to reject tumor cells are generated but fail to migrate to tumor sitesin IFN-γ-deficient mice. Can Res. 2001;61(8):3399–405.

CAS  Google Scholar 

Peng W, Liu C, Xu C, Lou Y, Chen J, Yang Y, et al. PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible ChemokinesPD-1 blockade improves the effectiveness of ACT for cancer. Can Res. 2012;72(20):5209–18.

Article  CAS  Google Scholar 

Liakou CI, Kamat A, Tang DN, Chen H, Sun J, Troncoso P, et al. CTLA-4 blockade increases IFNγ-producing CD4+ ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients. Proc Natl Acad Sci. 2008;105(39):14987–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakatani T, Kita Y, Fujimoto M, Sano T, Hamada A, Nakamura K, et al. IFN-gamma expression in the tumor microenvironment and CD8-positive tumor-infiltrating lymphocytes as prognostic markers in urothelial cancer patients receiving pembrolizumab. Cancers. 2022;14(2):263.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manguso RT, Pope HW, Zimmer MD, Brown FD, Yates KB, Miller BC, et al. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature. 2017;547(7664):413–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corrales L, Glickman LH, McWhirter SM, Kanne DB, Sivick KE, Katibah GE, et al. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep. 2015;11(7):1018–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature. 2009;461(7265):788–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nishikawa Y, Matsuzaki Y, Kimura K, Rokunohe A, Nakano H, Sawamura D. Modulation of stimulator of interferon genes (STING) expression by interferon-γ in human keratinocytes. Biochem Genet. 2018;56:93–102.

Article  CAS  PubMed